Pharmaceutical Technology

APRIL 3, 2023

The European Commission (EC) has granted marketing authorisation for Sandoz’s biosimilar Hyrimoz (adalimumab) citrate-free high-concentration formulation (HCF). The regulatory approval comes after a positive opinion was issued by the European Medicines Agency’s Committee on Medicinal Products for Human Use (CHMP) in January this year.

Marketing 264

Marketing Medicine Packaging Packaging 264

Drug Patent Watch

MARCH 31, 2024

Annual Drug Patent Expirations for IONSYS Ionsys is a drug marketed by The Medicines Co and is included in one NDA. There are eight patents protecting this drug. This drug… Source

Medicine 98

Medicine Drugs Marketing 98

Pharma Mirror

APRIL 21, 2024

The healthcare landscape is rapidly transforming, fueled by the convergence of technology and medicine. As we delve into the IoT in Healthcare Market Outlook for 2031, the data paints a vivid picture of an industry poised for unprecedented growth and innovation. In 2021, the industry was valued at an impressive US$ 91.71

Marketing 130

Marketing Medicine Research 130

pharmaphorum

MAY 31, 2023

PM Society’s ‘Securing Market Access to Medicines for England, Ireland, Scotland & Wales’ – part one Mike.Hammerton Wed, 05/31/2023 - 12:45 Bookmark this

Medicine 93

Medicine Marketing 93

Pharmaceutical Technology

DECEMBER 15, 2022

France’s temporary authorisation system (autorisation temporaire d’utilisation, ATU) was developed to provide early market access for treatments in therapeutic areas with unmet medical need, limited therapeutic alternatives, or where no authorised alternatives are available. 53% of medicines under ATU/early access treat oncology indications.

Medicine 147

Medicine Marketing Drugs Branding 147

Fierce Pharma

MAY 8, 2024

On Tuesday, the EMA said it had accepted a request from AZ and withdrawn the company’s marketing authorization for its COVID-19 shot Vaxzevria.

Vaccination 134

Vaccination Vaccine Marketing Medicine 134

Pharmaceutical Technology

JUNE 12, 2023

Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure.

Marketing 242

Marketing Production Branding Manufacturing 242

Bio Pharma Dive

AUGUST 22, 2022

After spiking on news of the merger’s close, shares in the ADHD treatment developer fell sharply in trading Monday and again on Tuesday.

Medicine 271

Medicine Marketing Development 271

JAMA Internal Medicine

NOVEMBER 19, 2023

This cross-sectional study examines the provenance and clinical benefit of medicines that entered the French market between 2008 and 2018 using the Prescrire and Haute Autorité de Santé grading systems.

Medicine 101

Medicine Marketing 101

Pharmaceutical Technology

APRIL 27, 2023

The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity. However, the reform has its share of critics. Applications will now be digitised.

Marketing 264

Marketing Medicine Production Clinical Trials 264

World of DTC Marketing

DECEMBER 4, 2020

Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June. ” Digital medicine also needs better clarification.

Medicine 201

Medicine Doctors Doctor Pharmacy 201

Drug Patent Watch

APRIL 24, 2024

Annual Drug Patent Expirations for AYVAKIT Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are four patents… Source

Medicine 59

Medicine Drugs Marketing 59

Pharmaceutical Technology

FEBRUARY 27, 2023

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorisation for Me rck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir).

Medicine 162

Medicine Regulation Trials Production 162

Outsourcing Pharma

MARCH 26, 2024

Under the agreement, Closed Loop Medicine â a leading TechBio company â and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicineâs proprietary software as a medical device (SaMD) technology platform.

Medicine 83

Medicine Regulation Marketing 83

Pharmaceutical Technology

JANUARY 17, 2024

In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.

Medicine 130

Medicine Marketing 130

Pharmaceutical Technology

JUNE 7, 2023

The European Commission (EC) has granted marketing authorisation for Fennec Pharmaceuticals’ Pedmarqsi (sodium thiosulfate) to reduce the risk of hearing loss in paediatric oncology patients. We look forward to making this important treatment available to the paediatric oncology community in the EU as soon as possible.”

Marketing 130

Marketing Medicine Trials Production 130

Pharmaceutical Technology

MAY 5, 2023

The European Medicines Agency’s (EMA) committee for medicinal products for human use (CHMP) has recommended full marketing authorisation (MA) for Gilead Sciences ’ Hepcludex (bulevirtide) to treat chronic hepatitis delta virus (HDV) and compensated liver disease in adult patients.

Marketing 147

Marketing Medicine Drugs Production 147

Pharmaceutical Technology

JULY 1, 2022

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects.

Medicine 147

Medicine Business Development Sales Life Science 147

Pharmaceutical Technology

JANUARY 4, 2023

Belharra Therapeutics and Roche Group member Genentech have announced a partnership for the discovery and development of new small molecule medicines across several therapeutic areas. Genentech will handle late preclinical, clinical activities of such molecules along with their regulatory development and marketing.

Medicine 130

Medicine Development Sales Production 130

Pharmaceutical Technology

APRIL 5, 2023

Luye Pharma Group has signed a marketing and distribution agreement with Duopharma Biotech’s wholly-owned subsidiary, Duopharma Marketing, for a cholesterol management product in Malaysia. Both the companies are targeting a double-digit compound annual growth rate for the product in the local market over the next ten years.

Production 130

Production Marketing Doctors Doctor 130

Pharmaceutical Technology

JUNE 8, 2023

The European Commission (EC) has granted marketing authorisation for GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, for adults aged 60 years and above. The EC approval follows a positive opinion from the European Medicines Agency’s committee on medicinal products for human use (CHMP) in April 2023.

Vaccination 147

Vaccination Vaccine Marketing Manufacturing 147

Pharmaceutical Technology

MAY 22, 2023

The European Medicines Agency (EMA) has accepted and verified Sobi’s marketing authorisation application for a new factor VIII (FVIII), efanesoctocog alfa, to treat haemophilia A patients of all ages.

Marketing 217

Marketing Genetics Trials Medicine 217

World of DTC Marketing

APRIL 20, 2022

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. This was especially true with new drugs that have a significant competitive market. Will they transform their HCP marketing or stick to dated models?

Marketing 218

Marketing Drug Trials Drugs Sales 218

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore. Topic sponsors are not involved in the creation of editorial content.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130

Drug Patent Watch

DECEMBER 26, 2023

Annual Drug Patent Expirations for AYVAKIT Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. There are three patents… The post New patent for Blueprint Medicines drug AYVAKIT appeared first on DrugPatentWatch - Make Better Decisions. It is available from one supplier.

Medicine 59

Medicine Drugs Marketing 59

Pharmaceutical Technology

APRIL 26, 2024

In Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question this market’s desirability for orphan drug developers.

Medicine 130

Medicine Development Drugs Marketing 130

BioSpace

DECEMBER 14, 2023

A European Medicine Agency panel on Friday reaffirmed its decision not to renew the conditional marketing authorization for GSK’s multiple myeloma drug Blenrep.

Marketing 97

Marketing Medicine Drugs 97

Pharmaceutical Technology

MAY 26, 2023

The European Medicines Agency (EMA) has accepted two marketing authorisation applications (MAA) from Sandoz for the proposed biosimilar denosumab. The MAAs include all indications covered by the Xgeva (denosumab) and Prolia (denosumab) reference medicines to treat conditions such as osteoporosis in postmenopausal women.

Marketing 130

Marketing Packaging Packaging Medicine 130

BioPharma Reporter

FEBRUARY 20, 2023

In 2022, the European Medicines Agency (EMA) recommended 89 medicines for marketing authorization: including six advanced therapy medicinal products and eight biosimilars.

Medicine 96

Medicine Marketing Production Regulation 96

pharmaphorum

MAY 5, 2023

Securing Market Access to Medicines for England, Ireland, Scotland Wales – The Landscape Ahead Mike.Hammerton Fri, 05/05/2023 - 07:20 Bookmark this

Medicine 52

Medicine Marketing 52

Pharmaceutical Technology

JANUARY 31, 2024

Germany’s Federal Ministry of Health has published its evaluation report on the impact of the GKV Financial Stabilization Act on access to medicines.

Marketing 130

Marketing Medicine 130

Pharmaceutical Technology

NOVEMBER 2, 2022

The European Medicines Agency (EMA) has granted full marketing authorisation (MA) for AstraZeneca ’s Covid-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]). The vaccine initially received a conditional marketing authorisation (cMA) for use in the European Union (EU).

Vaccination 147

Vaccination Vaccine Marketing Clinical Trials 147

Fierce Pharma

MAY 1, 2024

Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen.

Sales 114

Sales Marketing Medicine Production 114

Pharmaceutical Technology

JULY 7, 2022

But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine. It is certainly a pivotal moment for the cell and gene industry, with the next decade of R&D and clinical trials expected to transform the future of medicine. A new frontier in cancer research.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

BioPharma Reporter

MARCH 26, 2024

Teva UK and Closed Loop Medicine have announced a strategic partnership to advance the development of personalized medicine.

Medicine 52

Medicine Development Regulation Marketing 52

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 121

Medicine Life Science Marketing Clinical Trials 121

Pharmaceutical Technology

MARCH 1, 2024

Panama’s government expects to be a pioneer in the area through the centralisation of drug procurement with an emphasis on pharmacovigilance.

Medicine 147

Medicine Drugs Marketing 147